PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Sjögren's sufferers in extended safety trial
Disease control CompletedThis study looks at the long-term safety of a drug called efgartigimod for adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants had already completed a previous efgartigimod study. The drug works by lowering harmful antibodies…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 10:27 UTC
-
New Sjögren's drug shows promise in early safety trial
Disease control CompletedThis early-stage study tested a new drug called IBI355 in 30 adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal was to see if the drug is safe and how the body processes it. Participants received multiple doses, and researc…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 17, 2026 10:26 UTC